Stem Cell Therapy for Hair: Sessions, Cost, Where It Fits

Two patients ask about stem cells in completely different tones. One has read a study abstract and wants to argue about whether the evidence holds up. The other has already decided they want the treatment and simply wants to know how many appointments it takes and what it will cost.

We have written at length for the first patient. This article is for the second — the practical one. It is a service description with the sales voice removed: what the protocols are, who they are appropriate for, how the schedule works, what moves the price, and what a reasonable person should expect to see at month six.

The short answer: stem cell and placental stem cell therapy for hair is delivered as a course of scalp injections, typically 3 to 4 sessions spaced 4 to 6 weeks apart, with an annual or semi-annual top-up afterwards. It is appropriate for early to moderate thinning where follicles are miniaturising but still present, and for supporting native hair around a transplant. It is not a treatment for a fully bald zone. Pricing is quoted per plan after assessment — driven by session count and treated area — not as a single headline figure.

What Hairpol actually offers under this heading

“Stem cell” has become a marketing bucket that different clinics fill with very different things, so the first honest step is naming what we do and do not run.

We offer two distinct lines. The first is an autologous protocol built around stem cell therapy derived from your own tissue, processed on the day and reintroduced into the thinning area of the scalp. The second is a placental stem cell preparation — a standardised, externally sourced product delivered by the same injection route but without any harvesting step on your side.

Both are injectable scalp protocols. Neither involves growing hair in a laboratory, cloning follicles, or any of the things the phrase tends to conjure. If a clinic anywhere is promising you cultured follicles ready for implantation, that is not a service that exists in routine practice today, at any price.

How this article differs from our evidence piece

We already publish a deliberately sceptical read of this field. Stem cell and exosome therapies: hype, hope and what the evidence says examines trial quality, sample sizes and the gap between a promising mechanism and a proven outcome. It concludes, roughly, that the direction of travel is interesting and the certainty is lower than the marketing suggests.

Nothing here contradicts that. This piece answers a different question. If you have read the evidence article, accepted its caveats, and still want to know how the treatment is actually delivered — the schedule, the candidacy criteria, the cost drivers — that is what follows.

Keeping the two separate is intentional. A service page that pretends the evidence is settled is dishonest, and an evidence page that refuses to explain the service is unhelpful. You should be able to read both and reach your own position.

Autologous versus placental: the practical difference

The distinction matters more for your schedule and your comfort than for the theory.

The autologous route uses your own tissue, which means a harvesting step at the start of the session — a small sample taken under local anaesthesia, processed, and returned to the scalp within the same appointment. Its advantage is that the material is yours, so immune and allergy considerations are minimal. Its costs are a longer appointment and a small additional site that needs to heal.

The placental route removes the harvesting step entirely. The preparation is standardised, which means the content of session three matches session one rather than depending on what your tissue yielded that day. Appointments are shorter and there is no secondary healing site. In exchange, screening is stricter: medical history, allergy history and consent are handled in more detail, because you are receiving something that did not come from you.

Neither is automatically better. Patients who dislike additional procedures tend to prefer the placental route; patients who are uncomfortable with non-autologous material tend to prefer the other. That preference is a legitimate part of the decision and we treat it as such.

Who these protocols suit

The candidacy criteria are narrower than the advertising in this field implies, and stating them plainly saves everyone time.

Good candidates have miniaturising follicles that are still present. In practice that means: part the hair in the thinning zone and you see fine, short, pale hairs rather than bare scalp. Early androgenetic thinning, diffuse thinning across the mid-scalp in women, the recovery tail of a significant shedding episode, and native hair around a recent transplant all fit that description.

There is a second group worth naming: patients who cannot or will not take standard medication. Someone who has had side effects from finasteride, or who is planning a pregnancy, or who simply refuses a daily drug, has fewer options than the average patient. Injectable protocols do not replace what medication does, but for that group they are often the most reasonable remaining route. Any decision about starting, stopping or substituting a medication should still go through a doctor who has your history.

Who they do not suit

If the scalp is smooth and reflective with no visible hair shafts, no injectable protocol will change that. The follicle is not dormant; it has been replaced by fibrous tissue. Injecting into it is spending money on a biologically closed question.

Active scarring alopecia is an exclusion. So is any untreated inflammatory scalp condition, any active infection, and any situation where a systemic cause has not been investigated. If ferritin, thyroid function and the relevant hormonal panel have never been checked, that bloodwork comes first — it is cheaper, faster and more likely to change the outcome than any injection.

We also decline cases where expectations cannot be reconciled with the treatment. If someone has arrived expecting a Norwood 5 crown to regrow, the responsible answer is no, followed by a realistic conversation about grafts. That conversation starts on our hair transplantation page, and it is not a consolation prize — it is the treatment that actually addresses the problem.

How many sessions, and over how long

The standard course is 3 to 4 sessions, spaced 4 to 6 weeks apart, which puts a full course somewhere between three and five months from start to finish.

That spacing is not arbitrary. The hair cycle does not respond to anything on a weekly timescale, and compressing sessions into consecutive weeks produces more appointments without more effect. Stretching them beyond eight weeks, on the other hand, tends to blunt the cumulative effect the course is built on.

After the initial course, maintenance is where the long-term picture is decided. Most plans use one top-up session every 6 to 12 months. Patients who complete a course and then disengage entirely generally drift back toward their baseline trajectory across the following year, because nothing about the underlying cause has changed. That is not a failure of the protocol; it is what happens when you stop treating an ongoing process.

What a session is actually like

Allow around ninety minutes for an autologous session and forty-five to sixty for a placental one. The scalp is cleaned, a topical anaesthetic is applied and left to work for roughly fifteen minutes, and the injections are delivered in a grid across the treated zone at dermal depth.

The sensation is a series of quick pinpricks with pressure behind them. The hairline is more sensitive than the crown. Afterwards you will have small red dots for a few hours and occasionally mild tenderness overnight. Wash gently after twenty-four hours, skip the gym and the sauna for a day, and otherwise carry on. People routinely fly home the same evening.

Bring a list of your medications to the first session, including supplements. Anticoagulants, recent steroid courses and isotretinoin all change the plan, and it is better to know before you are in the chair.

Where it sits next to PRP, mesotherapy and G Cell

Patients often present these as competing products and ask which one wins. That framing does not survive contact with a real treatment plan.

PRP is autologous, cheap to run, well established and variable between patients. Mesotherapy describes a delivery method rather than a fixed formula, so its content varies enormously by clinic. G Cell is a standardised growth-factor preparation. Stem cell protocols sit at the more involved end of the same broad family of scalp injectables.

The practical rule is to run one line properly rather than sampling several. Stacking protocols in the same quarter multiplies the cost, makes it impossible to tell what produced any change you see, and gives the scalp no rest between appointments. If you want a wider view of the non-surgical options, our overview of hair treatments lays them out side by side.

Before or after a transplant?

Both windows are defensible, and they do different jobs.

Before surgery, a course improves the condition of the recipient area and clarifies which native hairs are salvageable. That has a direct planning consequence: a surgeon who can see which hairs will survive plans graft placement differently from one who is guessing.

After surgery, the target is the native hair between the new grafts. A transplant does nothing for those hairs, and they are a large part of what makes a result look dense at month six rather than month twelve. We generally wait until the scalp has fully settled, commonly month two to month three, before starting a course, and we time it to run through the stretch where shock loss is most visible.

If you are unsure whether you are a treatment case, a surgical case or both, send daylight photographs of the front, top and crown with no product in the hair — a photo assessment usually settles it within a day, and you can request one here without committing to a plan.

Fitting a course around travel

This is the logistical problem nobody mentions in the brochures. Sessions are spaced four to six weeks apart, and most of our injectable patients do not live in Istanbul. Three or four separate flights for three or four appointments is not a plan most people will actually complete, and a course abandoned after session two is money spent on nothing.

There are two workable routes. The first is to schedule the course around a trip you are already making — patients who come for surgery frequently start a course at the post-operative review and continue it on follow-up visits, which compresses the travel into journeys that were happening anyway. The second is to run the first session here and the remainder with a clinician near you, which requires that the protocol be documented properly and that someone local is willing to continue it.

We say this out loud because the alternative is quietly selling a course we know a patient will not finish. If neither route is realistic for you, the honest recommendation is to put the money toward something that does not require repeat visits — a surgical plan, or a medication regimen your own doctor manages — rather than starting a schedule that will break in November.

Ask any clinic quoting you a course how they handle the travel problem. If the answer is vague, the plan was designed around the invoice rather than around you.

What it costs and what drives the number

Here is where we will be more careful than most pages you will read on this subject. We do not publish a single headline figure for injectable courses, because a single figure would be misleading.

Three variables drive the quote. The number of sessions in the plan, which ranges from three to four for a standard course. The treated surface area — a frontal zone is not the same as a full mid-scalp and crown, and the volume of material required differs accordingly. And the protocol itself: autologous sessions involve a harvesting and processing step that placental sessions do not.

Surgery is different, and we do publish those figures because they are stable: scalp work sits in a $2,500 to $5,000 band depending on graft count and technique, and beard or eyebrow cases are a flat $2,500 package. Patients frequently assume treatments must be priced the same way. They are not, and the comparison is worth understanding before you start collecting quotes — our breakdown of what surgical pricing actually covers explains why a package model works for an operation and not for a course.

What you should insist on, from us or anyone else, is a written plan: number of sessions, interval, area treated, what maintenance will cost, and what happens if the mid-course review shows no change. A course quoted as one number with no session count attached is not a quote.

What realistic results look like

Nothing visible happens in the first month, and anyone who tells you otherwise is describing a placebo effect or selling something. A hair shaft grows about a centimetre a month, and a follicle that has been signalled to thicken still has to push that thicker shaft out through the skin.

The sequence most patients experience: a brief increase in shedding in the first few weeks, which is usually the hair cycle synchronising rather than a bad sign; less hair in the shower drain by months two to three; improved shaft calibre between months three and six, which reads to the eye as fuller rather than more numerous; and stabilisation by month twelve, with maintenance deciding whether the gain holds.

We photograph the same zones under the same light at session one and at the mid-course point, because self-assessment in a bathroom mirror is close to worthless. If calibre has not moved by the mid-course review in a scalp that should have responded, we say so and change the plan rather than selling you the rest of the course. That stopping criterion is the part you should ask every clinic about.

Safety, consent and the questions worth asking

The protocols are well tolerated. Expected effects are local and short-lived: redness, small injection points, occasional tenderness for a day. Infection is rare with proper technique and preparation.

The consent conversation for a non-autologous preparation is necessarily longer, and it should be. You are entitled to know the source and the standardisation of anything injected into your scalp, to have your allergy and medical history reviewed properly before the first session, and to receive a written record of what was used. A clinic that treats those questions as an inconvenience has told you something useful about itself.

Practical logistics for visiting patients are covered on our frequently asked questions page. The clinical part belongs in a conversation with someone who has looked at your scalp under magnification.

Deciding without the hype

Here is the framing we give patients who are genuinely torn. Injectable protocols are for preserving and improving hair that still exists. Surgery is for replacing hair that has gone. The two are sequential rather than competitive, and starting treatment while there is still something to preserve is worth considerably more than starting after the window has closed.

If you are early in the process, a properly run course with honest expectations and a real maintenance plan is a reasonable way to buy time. If the scalp already shows through in daylight, no protocol in this category will change that, and the honest conversation is a surgical one.

And if you are still weighing the evidence rather than the logistics, go back to the sceptical article and read it again. We would rather you arrived at a treatment decision with your doubts intact than with them marketed away.